Table 1.
Mean | SD | |
---|---|---|
Age | 39.8 | 12.3 |
N | % | |
Gender | ||
Male | 119 | 77.8 |
Female | 34 | 22.2 |
Education level | ||
None | 1 | 0.7 |
Primary school | 8 | 5.2 |
Lower secondary school | 36 | 23.5 |
High school | 82 | 53.6 |
Bachelor's degree/Postgraduate degree | 24 | 15.7 |
Relationship status | ||
Single | 66 | 43.1 |
Widow / widower | 1 | 0.7 |
Divorced | 22 | 14.4 |
In a relationship | 51 | 33.3 |
In a relationship but not seeing each other till the beginning of the lockdown | 11 | 7.2 |
Having children | ||
Yes | 33 | 21.6 |
No | 95 | 62.1 |
Mean | SD | |
Days spent in lockdown | 47.3 | 14.1 |
N | % | |
Quarantine violations | ||
Yes | 26 | 17.0 |
No | 123 | 80.4 |
Not in quarantine | 3 | 2.0 |
Sars-Cov2 testing | ||
Negative | 33 | 21.6 |
Positive | 3 | 2.0 |
None | 116 | 75.8 |
Data unavailable | 1 | 0.7 |
Cigarette smoking | ||
No | 32 | 20.9 |
Yes occasionally | 12 | 7.8 |
Yes < 10 cigarettes/day | 24 | 15.7 |
Yes 10-20 cigarettes/day | 57 | 37.3 |
Yes > 20 cigarettes/day | 27 | 17.6 |
Primary substance/behavior of abuse | ||
Cocaine | 66 | 43.1 |
Alcohol | 39 | 25.5 |
THC | 24 | 15.7 |
Gambling | 12 | 7.8 |
Heroin | 9 | 5.9 |
Benzodiazepines | 1 | 0.7 |
Ketamine | 1 | 0.7 |
Psychopharmacological medications | 1 | 0.7 |
Secondary substance/behavior of abuse | ||
Cocaine | 12 | 7.8 |
Alcohol | 14 | 9.2 |
THC | 17 | 11.1 |
Gambling | 20 | 13.1 |
Opioids | 4 | 2.6 |
MDMA / Meth-amphetamines | 3 | 2.0 |
Nicotine | 1 | 0.7 |
Not specified | 4 | 2.6 |
None | 78 | 51.0 |
Gambling | ||
Yes | 33 | 21.6 |
No | 109 | 71.2 |
In the past | 11 | 7.2 |
Days from the last use of the primary substance | 95.6 | 81.6 |
N | % | |
Followed by an Addiction Service | ||
Yes | 93 | 60.8 |
No | 60 | 39.2 |
Substitute and/or support treatments | ||
Methadone | 11 | 7.2 |
Buprenorphine | 3 | 2.0 |
Naloxone/naltrexone | 4 | 2.6 |
Sodium oxybate | 8 | 5.2 |
Disulfiram | 1 | 0.7 |
Hospitalization | ||
Inpatients | 56 | 36.6 |
Outpatients | 97 | 63.4 |
THC: Δ9-tetrahydrocannabinol; MDMA: methylenedioxymethamphetamine.